Back to search

Article

Not All Predictors Of RCC Clusters Are The Same: An individual sample predictive model to classify patients with metastatic renal cell carcinoma

2026-06-29

Abstract excerpt

Clear cell renal cell carcinoma (RCC) patients have multiple approved therapies, including anti-angiogenesis tyrosine kinase inhibitors (TKIs) and immuno-oncology therapies (IO), but lack a clinically validated biomarker. Using RNAseq data from the IMmotion 151 clinical trial (IM151) 1–3 , 7 RCC biologic clusters have been defined 3 . Several groups have attempted to predict these clusters on various RCC dataset...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
538f6b8e-5f3b-50ab-b942-5412a40f49ad
DOI
10.64898/2026.06.24.734285
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Not All Predictors Of RCC Clusters Are The Same: An individual sample predictive model to classify patients with metastatic renal cell carcinomaDOI 10.64898/2026.06.24.734285
Select a neighboring publication to make it the new centre.